Manama: The National Health Regulatory Authority (NHRA) has announced the withdrawal and suspension of registration of the pharmaceutical product “PROTON 40mg E.C TABLET – PROTON 20mg E.C TABLET”, produced by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO). The move is based on the warning issued by the Saudi Food and Drug Authority (SFDA) on March 12, 2021. The NHRA indicated said that it has withdrawn the medicine from the Kingdom, and suspended its registration because it does not match the original product. The NHRA recommended the health authorities to withdraw the product as soon as it is available to them, calling on the medicine users to contact their doctors to receive the alternative medication.
Trending
- Traffic Directorate announces new regulations for use of electric bikes and scooters
- Court sentences defendants in two terrorism cases of communication with Iran’s Revolutionary Guard
- Mumtalakat reports another record year with profits rising to BHD 592.7 million
- Amal Al Fardan wins gold, bronze at African Open Championship
- Labour Minister receives AGU President
- Shanxi mine accident in China leaves 82 dead, 9 missing
- George Russell wins sprint race at Formula One Canadian Grand Prix
- Antonelli tops practice sessions at the Canadian Grand Prix in Formula 1
